COMMUNIQUÉS West-GlobeNewswire

Spero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform
23/05/2018
SPR741 Phase 1b Drug-Drug Interaction Study and SPR206 IND-enabling Studies Provide Support for Further Clinical Development Phase 1b data demonstrates pharmacokinetic compatibility and tolerability of SPR741 when co- [...]
BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference
23/05/2018
RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]
Golden Leaf Holdings to Hold Conference Call to Review First Quarter 2018 Results
23/05/2018
TORONTO, May 23, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized brands, [...]
Guardian™ Connect Continuous Glucose Monitoring (CGM) System Now Licensed in Canada for People Living With Diabetes
23/05/2018
Standalone CGM System Helps People Using Insulin Injections to Know More and Guess Less BRAMPTON, Ontario, May 23, 2018 (GLOBE NEWSWIRE) -- Medtronic Canada, a subsidiary of Medtronic plc (NYSE: MDT ) today announced it [...]
Le système de surveillance du glucose en continu (SGC) GuardianMC Connect est désormais homologué au Canada pour les personnes vivant avec le diabète
23/05/2018
Le système autonome de SGC aide les personnes qui ont recours aux injections d’insuline à avoir plus d’information et moins d’incertitudes BRAMPTON, Ontario, 23 mai 2018 (GLOBE NEWSWIRE) -- Medtronic Canada, une filiale [...]
DLT Resolution Records Strong Sales Growth & Records First Earnings
23/05/2018
Las Vegas, NV, May 23, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) and Information Technology company that services the healthcare and telecommunications [...]
Emerald Health Therapeutics Closes $16.8 Million Prospectus Sale
23/05/2018
VICTORIA, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) ("Emerald" or the “Company”) has closed its prospectus sale (the “Offering”) to a single Canadian [...]
Repligen to Present at Jefferies 2018 Global Healthcare Conference
23/05/2018
WALTHAM, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ), a global bioprocessing company focused on the development and commercialization of highly innovative technologies to improve [...]
Announcement from Acarix's annual general meeting
23/05/2018
Announcement from Acarix's annual general meeting The annual general meeting (" AGM ") of Acarix AB (" Acarix " or the " Company ") was held today on 23 May 2018 and the following resolutions were passed by the meeting [...]
Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob™ Technology Platform in China
23/05/2018
HINGHAM, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
Align Technology Hosts 2018 Investor Day
23/05/2018
Highlights Innovative Digital Platform Reinforces Strong Company Growth Reaffirms Guidance Announces Stock Repurchase Program NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) will host [...]
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
23/05/2018
ALACHUA, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, [...]
ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board
23/05/2018
LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR ), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Clementia Reports Positive Phase 2 Part B Data Showing Treatment with Palovarotene Significantly Reduces New Bone Growth in Patients with FOP
23/05/2018
Statistically Significant 91% Reduction of New HO at Flare-up Sites at 12 Weeks; 65% Reduction of New HO at 12-Month WBCT Scan Evaluable Patients with No New Bone at 12 Weeks Had No New Bone at 12 Months Company to Host [...]
Clementia annonce l’obtention de données positives de la partie B de la phase 2 démontrant que le traitement par palovarotene peut considérablement réduire le développement d’une nouvelle croissance osseuse chez des patients souffrant de FOP
23/05/2018
Réduction statistiquement significative de 91 % de nouvelle OH aux sites de poussées à la semaine 12; réduction de 65% de nouvelle OH lors de la TDM du corps entier au mois 12 Les patients évaluables n’ayant pas [...]
Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors
23/05/2018
Press release Malmö, May 23, 2018 Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors Acarix, developer of the CADScor®System for Coronary Artery Disease (CAD) risk [...]
PotNetwork Holdings' Diamond CBD, Inc. Puts Smack Down on Bullying Through Alliance with Former MMA Pro,Carlos Flores, and the Bully Rehab Awareness Gym
23/05/2018
Company Moves to Break Into MMA, the Fastest-Growing Sport on the Planet FT. LAUDERDALE, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce that [...]
Capital Senior Living Corporation to Present at the Jefferies 2018 Healthcare Conference on Tuesday, June 5, 2018
23/05/2018
DALLAS, May 23, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that management will make a [...]
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVA™ Injection in Dialysis Patients with Pruritus
23/05/2018
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million Cara eligible for up to $470 million in regulatory and commercial milestones VFMCRP to commercialize KORSUVA injection [...]

Pages